129 related articles for article (PubMed ID: 15579165)
1. Extensive exercise is not harmful in amyotrophic lateral sclerosis.
Liebetanz D; Hagemann K; von Lewinski F; Kahler E; Paulus W
Eur J Neurosci; 2004 Dec; 20(11):3115-20. PubMed ID: 15579165
[TBL] [Abstract][Full Text] [Related]
2. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
3. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
4. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
5. Decline in daily running distance presages disease onset in a mouse model of ALS.
Bruestle DA; Cutler RG; Telljohann RS; Mattson MP
Neuromolecular Med; 2009; 11(2):58-62. PubMed ID: 19418268
[TBL] [Abstract][Full Text] [Related]
6. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
7. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis.
Kruman II; Pedersen WA; Springer JE; Mattson MP
Exp Neurol; 1999 Nov; 160(1):28-39. PubMed ID: 10630188
[TBL] [Abstract][Full Text] [Related]
8. Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice.
Hamadeh MJ; Tarnopolsky MA
Muscle Nerve; 2006 Dec; 34(6):709-19. PubMed ID: 16941656
[TBL] [Abstract][Full Text] [Related]
9. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
Tanase K; Teng Q; Krishnaney AA; Liu JK; Garrity-Moses ME; Boulis NM
J Neurosurg Spine; 2004 Jul; 1(1):128-36. PubMed ID: 15291033
[TBL] [Abstract][Full Text] [Related]
10. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease.
Tortarolo M; Grignaschi G; Calvaresi N; Zennaro E; Spaltro G; Colovic M; Fracasso C; Guiso G; Elger B; Schneider H; Seilheimer B; Caccia S; Bendotti C
J Neurosci Res; 2006 Jan; 83(1):134-46. PubMed ID: 16323214
[TBL] [Abstract][Full Text] [Related]
11. Early abnormalities in transgenic mouse models of amyotrophic lateral sclerosis.
Durand J; Amendola J; Bories C; Lamotte d'Incamps B
J Physiol Paris; 2006; 99(2-3):211-20. PubMed ID: 16448809
[TBL] [Abstract][Full Text] [Related]
12. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD
J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335
[TBL] [Abstract][Full Text] [Related]
13. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
14. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
Mahoney DJ; Rodriguez C; Devries M; Yasuda N; Tarnopolsky MA
Muscle Nerve; 2004 May; 29(5):656-62. PubMed ID: 15116368
[TBL] [Abstract][Full Text] [Related]
15. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
[TBL] [Abstract][Full Text] [Related]
17. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.
Kim K; Moore DH; Makriyannis A; Abood ME
Eur J Pharmacol; 2006 Aug; 542(1-3):100-5. PubMed ID: 16781706
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS.
Zheng C; Nennesmo I; Fadeel B; Henter JI
Ann Neurol; 2004 Oct; 56(4):564-7. PubMed ID: 15389897
[TBL] [Abstract][Full Text] [Related]
19. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Niessen HG; Debska-Vielhaber G; Sander K; Angenstein F; Ludolph AC; Hilfert L; Willker W; Leibfritz D; Heinze HJ; Kunz WS; Vielhaber S
Eur J Neurosci; 2007 Mar; 25(6):1669-77. PubMed ID: 17432958
[TBL] [Abstract][Full Text] [Related]
20. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
Morrison BM; Morrison JH; Gordon JW
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
